Mr. Surendra Sharma discusses several congenital heart diseases including their definitions, causes, pathophysiology, clinical manifestations, diagnostic evaluations, and management. He provides details on ventricular septal defect (VSD), atrial septal defect (ASD), patent ductus arteriosus (PDA), tetralogy of Fallot, transposition of the great arteries, coarctation of the aorta, and pulmonary stenosis. The document contains in-depth information on the incidence, characteristics, and treatment of these common congenital heart conditions.
Congenital heart disease (congenital heart defect) is one or more abnormalities in your heart's structure that you're born with. This most common of birth defects can alter the way blood flows through your heart.
commonly used for medical students, and helpful to use this ppt to study for them, and also a common man can understand very easily what is coarctation of aorta.
Congenital heart disease is one or more problems with the heart's structure that exist since birth. Congenital means that you're born with the defect. Congenital heart disease, also called congenital heart defect, can change the way blood flows through your heart. IF YOU LIKE GIVE YOUR LIKES AND FOLLOW THIS LINK
Congenital heart disease (congenital heart defect) is one or more abnormalities in your heart's structure that you're born with. This most common of birth defects can alter the way blood flows through your heart.
commonly used for medical students, and helpful to use this ppt to study for them, and also a common man can understand very easily what is coarctation of aorta.
Congenital heart disease is one or more problems with the heart's structure that exist since birth. Congenital means that you're born with the defect. Congenital heart disease, also called congenital heart defect, can change the way blood flows through your heart. IF YOU LIKE GIVE YOUR LIKES AND FOLLOW THIS LINK
A cyanotic heart defect is a group-type of congenital heart defects (CHDs). The patient appears blue (cyanotic), due to deoxygenated blood bypassing the lungs and entering the systemic circulation. This can be caused by right-to-left or bidirectional shunting, or malposition of the great arteries.
Cyanotic heart defects, which account for approximately 25% of all CHDs, include:
Tetralogy of Fallot (ToF)
Total anomalous pulmonary venous connection
Hypoplastic left heart syndrome (HLHS)
Transposition of the great arteries (d-TGA)
Truncus arteriosus (Persistent)
Tricuspid atresia
Interrupted aortic arch
Pulmonary atresia (PA)
Pulmonary stenosis (critical)
Eisenmenger syndrome(Reversal of Shunt due to Pulmonary Hypertension) .
Patent ductus arteriosus may cause cyanosis in late stage.
Some babies with tricuspid atresia have other conditions, such as pulmonary stenosis or transposition of the great arteries, that also affect blood flow through their heart. These conditions require treatment, too.
Pulmonary stenosis (also called pulmonic stenosis) is when the pulmonary valve (the valve between the right ventricle and the pulmonary artery) is too small, narrow, or stiff. Symptoms of pulmonary stenosis depend on how small the narrowing of the pulmonary valve is
These are cardiac anomalies arising as a result of a defect in the structure or function of the heart and great vessels which is present at birth
These lesions either obstruct blood flow in the heart or vessels near it, or alter the pathway of blood circulating through the heart
A cyanotic heart defect is a group-type of congenital heart defects (CHDs). The patient appears blue (cyanotic), due to deoxygenated blood bypassing the lungs and entering the systemic circulation. This can be caused by right-to-left or bidirectional shunting, or malposition of the great arteries.
Cyanotic heart defects, which account for approximately 25% of all CHDs, include:
Tetralogy of Fallot (ToF)
Total anomalous pulmonary venous connection
Hypoplastic left heart syndrome (HLHS)
Transposition of the great arteries (d-TGA)
Truncus arteriosus (Persistent)
Tricuspid atresia
Interrupted aortic arch
Pulmonary atresia (PA)
Pulmonary stenosis (critical)
Eisenmenger syndrome(Reversal of Shunt due to Pulmonary Hypertension) .
Patent ductus arteriosus may cause cyanosis in late stage.
Some babies with tricuspid atresia have other conditions, such as pulmonary stenosis or transposition of the great arteries, that also affect blood flow through their heart. These conditions require treatment, too.
Pulmonary stenosis (also called pulmonic stenosis) is when the pulmonary valve (the valve between the right ventricle and the pulmonary artery) is too small, narrow, or stiff. Symptoms of pulmonary stenosis depend on how small the narrowing of the pulmonary valve is
These are cardiac anomalies arising as a result of a defect in the structure or function of the heart and great vessels which is present at birth
These lesions either obstruct blood flow in the heart or vessels near it, or alter the pathway of blood circulating through the heart
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
2. INCIDENCE:
The overall incidence of congenital heart diseases
is about
8 – 10 percent per 1000 live births
Defect Percentage
VSD 25 – 30 %
PDA 10 %
ASD 10 %
Coarctation of aorta 6 %
TOF 5- 9 %
3. ETIOLOGY AND INCIDENCE
Hereditary factors
CHD affects 8 – 12 of every 1000 neonates
Associated factor for CHD include
Ø Fetal or Maternal infection during the first trimester
(Rubella)
Ø Chromosomal abnormality (Trisomy 21, 18, 13)
Ø Maternal diabetes
Ø Teratogenic effects of drugs and alcohol
Syndromes that include CHD
Ø Marfan`s syndrome : Mitral value prolapse
Ø Turner’s syndrome : Aortic value stenosis, COA
Ø William’s syndrome : Dysplastic pulmonary value
Ø Down syndrome : Triosomy
4. Congenital Heart diseases
Cyanotic heart Acyanotic heart Obstructive
diseases ( R to L shunt ) diseases ( L to R ) .Coarctation
of aorta
Fallots tetrology . VSD . Vascular ring
Transposition of greater . ASD . Pulmonary
stenosis
vessels
. PDA . Aortic stenosis
Tricuspid atresia
5. VENRICULAR SEPTAL DEFECT (VSD)
Definition
VSD is an abnormal communication between the two ventricles
6.
7.
8. Pathophysiology
Blood is shunted from the left to the right ventricles in most of the
cases due to the relatively high pressure of the left ventricles chamber
If the defect is large, the amount of blood shunted in to the right
ventricles may be quite large resulting in increased workload for both
ventricles
Right ventricles increased right ventricular out put and pulmonary
enlargement develops
Blood increased return to the left atrium, thus increasing the work
of the left ventricles, resulting in bi – ventricular hypertrophy
Pulmonary over circulation cause a change in the pulmonary
arterial bed, leading to increased pulmonary artery vascular resistance
High pulmonary vascular resistance can reverse the blood flow pattern
that leads to right to left shunt across the VSD
(Eisenmenger`s Syndrome) resulting in cyanosis
9. Clinical manifestation
Small VSD`s : usually a symptomatic; High spontaneous closure
rate during the first year of life
Large VSD`s:
CHF – tachypnea, tachycardia, excessive sweating
Frequent URI
Poor weight gain, Failure to thrive
Feeding difficulties
Murmur present
Pulmonary vascular obstructive diseases
10. Investigation
X. - ray chest - ventricular hypertrophy
Small -Normal
Moderate VSD - shunt vascularity (pulmonary plethora)
Ventricular hypertrophy
o Pulmonary artery increased size.
Large VSD - Biventricular hypertrophy
Increased pulmonary trunk
Left arterial enlargement.
– Enlarged main pulmonary artery
--- Right ventricular hypertrophy
--- Peripheral pruning with apparent decrease in shunt
--- vascularity.
12. ECG
Echo and Doppler study
Cardiac cauterization study
Angiocardiography
13. Management of VSD:
Aims: -
1. To achieve normal growth by controlling ccf
2. Prevention and treatment of anemia
3. Prevention and treatment of infective endocarditis
14. 1. Medical management: -
1.CHF management :digoxin and diuretics(furasemide,
spironolactone) and after reduction
2. Avoid oxygen : - oxygen is a potent pulmonary
vasodilator and will increase blood flow in to the P.A
3.Increase caloric intake: fortify formula or breast milk to
make 24 to 30 caloz formula, supplemental
nasogastric feeds as needed.
4.Ineffective endocarditis prophylaxis for 6 months after
surgery.
2.Surgical treatment: -
Corrective surgery done in first 2 years of life prevents
progression of pulmonary hypertension
15. Surgeries: -
1.Corrective surgery –patch graft – Dacron / Natural
2.Palliative surgery – Pulmonary artery banding
Complication:
1.C.H.F
2.Recurrent respiratory tract infection
3.Ineffective endocarditis
4.Failure to thrive: poor weight gain
5.Pulmonary arterial hypertension and
elsenmengerisation
6.Aortic or tricuspid regurgitation
7.Right ventricular outflow tract obstruction.
17. Pathophysiology:
Blood flows from the higher pressure left atrium
across the ASD in to the lower pressure right atrium.
Increased blood return to the right heart leads to right
ventricular volume over load.
Right ventricular dilatation
Increased pulmonary blood flow leads to elevated
pulmonary artery pressure.
18.
19. Clinical manifestation: -
1. Usually a symptomatic
2. CHF
3. Frequent upper respiratory tract infection
4. Poor weight gain
5. Decreased exercise tolerance.
Diagnostic evaluation: -
1. X-Ray Right atrial and ventricular enlargement-
enlargement of pulmonary artery
2. E.C.G
3. Auscultation: soft systolic ejection murmur heard best at
the left upper sternal border.
4. Cardiac caterization
20. Management: -
1.Medical management
a).Monitor and reassess
b).Treatment with anticongestive therapy (digoxin and
lasix) may be necessary. if signs of CHF are present
c).Infective endocarditis prophylaxis for 6 months after
surgery or atrial occlusion devise is used.
2. Cardiac catherisation for placement of an atrial occlusion
device for ostium secundam defects.
3.Surgical intervention:
a) Primary repair suture closure of the ASD.
b) Patch repair of the ASD.
22. Patent ductus arteriosus (PDA)
Definition
This defect, which normally occurs during fetal life, short
circuits the normal pulmonary vascular system and allows
blood to mix between the pulmonary artery and the aorta.
Prior to birth, there is an open passageway between the two
blood vessels, which closes soon after birth. When it does
not close, some blood returns to the lungs. Patent ductus
arteriosus is often seen in premature infants.
23. Pathophysiology:
During fetal life, the ductus arteriosus allows blood to by pass the
pulmonary circulation and flow directly in to the systemic circulation.
After birth, the ductus arteriosus is no longer needed. Functional closure
usually occurs within 48 hrs after birth.
When the ductus arteriosus fails to close blood from the aorta ( high
pressure) flows in to the lower pressure PA.
Resulting in pulmonary over circulation
Increased pulmonary blood flow leads to a volume- loaded LV.
24.
25. Clinical manifestation:
1. Growth retardation
2. External dyspnea
3. CCF
4. Pericardial pain
5. Cough
6. Dyspnoea
7. Tachypnoea.
8. Dyspnoea
9. Tacycardia
10. Hepato splenomegali
11. Machinery murmur. It is harsh and may be localized to
second left intercostals space or transmitted to left
clavicle to lower down (ie) left sternal border. It is
accomplished by a thrill.
26. Diagnostic evaluation: -
Chest X-Ray- cardiomegaly
ECG
ECHO
Cardiac catherization; raised pressure in right ventricles and
pulmonary artery.
Management: -
1.In the symptomatic premature neonate; Indomethacin. Given IV.
2.Medical management:
a) Monitor growth and development
b) Reassures for spontaneous PDA closure
c) Increase caloric intake as needed for normal weight gain
d) Diuretics: furusemide (lasix), spironolactone (Aldactone).
e) Ineffective endocarditis prophylaxis for 6 months after surgery.
27. 3.Cardiac catherization:
a) For small PDAs coil occlusion
b) For large PDAs closure device may be used.
4.Surgical management through PDA ligation.
Complication:
1. CHF, pulmonary oedema
2. Infective endocarditis
3. Pulmonary hypertension
4. Recurrent pneumonia.
30. PATHOPHYSIOLOGY
The blood normally returns from the systemic circulation to the
systemic circulation to the right atrium and right ventricles
The outflow of blood from the right ventricles is resisted by the
pulmonary stenosis so that the blood flows through the ventricular
septal defect in to the aorta
There is right to left shunt. Hypertrophy of the right ventricles occurs
as a result of the pressure exerted against the pulmonary stenosis.
Because, the blood from the right ventricles is unoxygenated, cyanosis
results.
31. Clinical manifestation: -
1. Cyanotic episodes: cyanotic spells may occur while
crying and after feeding. After cyanotic spells, there
may be limpness, fatigue and fainting.
2. Dyspnoea
3. Delayed physical growth and development
4. Pansystolic murmur may be heard at the middle to lower
sternal borders
5. Cyanosis- may be seen mucous membrane of the lips,
mouth and pharynx and in fingernails and toe- nails.
6. Clubbing of the fingers
7. Paroxysmal dyspneic attacks (anoxia, “ blue “ spells)
occur during the first 24 months of life and last for a
few minutes to hours.
32. Diagnosis: -
1. Blood studies.
2. X-Ray chest
3. ECG- right ventricular hypertrophy.
4. Echo- evidence of the aortic override, thick anterior right
ventricular wall and large aorta.
Medical and Nursing management:
Palliative and corrective surgery for tetrology of fallot is
being done in infants and children of all ages.
33. Transposition of the great arteries
This congenital heart defect, the positions of the pulmonary
artery and the aorta are reversed, thus:
o The aorta originates from the right ventricle, so most of the
blood returning to the heart from the body is pumped back out
without first going to the lungs.
o The pulmonary artery originates from the left ventricle, so that
most of the blood returning from the lungs goes back to the
lungs again
34.
35.
36. Pathophysiology: -
In this anomaly the aorta has its origin in the right ventricles and
pulmonary artery has its origins in the left ventricles.
Hence, the aorta carries unoxygenated blood to the systemic circulation
and the pulmonary circuit carries oxygenated blood back to the lungs.
The pulmonary venous return is to the left atrium and the systemic
veins returns to the right atrium.
There is two separate circulatory systemic exist, one pulmonary and
one systemic. An infant can survive with this malformation initially only
if an associated with defect or PDA is present
There co-existing lesions provide a means for mixing venous and arterial
blood.
37. Clinical manifestation: -
1. Cyanosis from neonatal period and polycythemia
2. Congestive cardiac failure
3. Hypercapnoea due to low arterial oxygen
4. Delayed growth and development
5. Metabolic acidosis
6. Clubbing of the finger and toes.
Diagnostic evaluation: -
1. Physical examination – if defect is there murmur can be heard
2. X-ray- cardiomegaly and increased pulmonary vasculature
3. Fluoroscopy- egg shaped” cardiac contour can be identified
4. Echo- Right ventricular hypertrophy
5. ECG
6. Angiocardiography
Cardiac catherization
38. Treatment: -
Procedure used for the treatment of transposition of the
great vessels are palliative and corrective.
39. Coarctation of the aorta
Aortic coarctation is a narrowing of part of the
aorta (the major artery leading out of the heart). It
is a type of birth defect. Coarctation means
narrowing. It accounts for 8 -10% of CHD and is 2
to 5 time more common in male.
42. Causes
The aorta carries blood from the heart to the vessels
that supply the body with blood and nutrients. If part
of the aorta is narrowed, it is hard for blood to pass
through the artery.
Aortic coarctation is more common in Turner
syndrome.
Coarctation of the aorta may be seen with other
congenital heart defects, such as:
Bicuspid aortic valve
Defects in which only one ventricle is present
Ventricular septal defect
43. Clinical manifestation
Asymptomatical until the PDA begin to close
After PDA closure:-
Sever CHF
Tachypnea
Acidosis
Prograsive circulatory shock
Absent femoral and pedal pulses
44. Chest pain
Cold feet or legs
Dizziness or fainting
Decreased ability to exercise
Failure to thrive
Leg cramps with exercise
Nosebleed
Poor growth
Pounding headache
45. Diagnostic evaluation
1. Physical examination –The pulse in the groin
(femoral) area or feet will be weaker than the pulse in
the arms or neck (carotid). Sometimes, the femoral
pulse may not be felt at all and murmur sound can be
heard ,
2. X-ray- cardiomegaly
3. ECG
4. Echo- Right ventricular hypertrophy
5. Angiocardiography
6. Cardiac catherization
7. Heart CT may be needed in older children
8. MRI or MR angiography of the chest may be
needed in older children
46. Management
1. Medical Menagement
Resuscitation and stabilization with Prostaglandin E1
infusion
Intubation and ventilation as needed
Infective endocarditis prophylaxis
Anticongestive theraphy( digixin and lasix)
Assessment of renal ,hepatic,and nurologic function.
2. Ballon angioplasty may be indicated for infants who are a
high surgical risk.
3. Surgical intervention: usually performed as soon as the
diagnosis is made
Subclavian flap repair
End to end anastomosis
Dacron patch repair
47. Complication
Aortic aneurysm
Endocarditis (infection in the heart)
Heart failure
Kidney problems
Paralysis of the lower half of the body (a rare
complication of surgery to repair coarctation)
Severe high blood pressure
48. Pulmonary stenosis
Pulmonary valve stenosis is a heart valve
disorder that involves the pulmonary valve.
This valve separates the right ventricle (one of
the chambers in the heart) and the pulmonary
artery. The pulmonary artery carries oxygen-poor
blood to the lungs.
Stenosis, or narrowing, occurs when the valve
cannot open wide enough. As a result, less blood
flows to the lungs.
49.
50. Causes
Narrowing of the pulmonary valve is usually
present at birth (congenital). It is caused by a
problem that occurs when the unborn baby (fetus)
is developing. The cause is unknown, but
genetics may play a role.
Pulmonary valve stenosis is a rare disorder.
In some cases, pulmonary valve stenosis more in
families.
51. Clinical manifestation
These infants are usually found to have a murmur on a
routine heart examination.
When the valve narrowing (stenosis) is moderate to
severe, the symptoms include:
Bluish color to the skin (cyanosis) in some patients
Chest pain
Fainting
Fatigue
Poor weight gain or failure to thrive in infants with severe
blockage
Shortness of breath
Sudden death
Symptoms may get worse with exercise or activity.
52. Diagnostic evaluation
Physical examination:- The health care provider
may hear a heart murmur when listening to your
heart using a stethoscope. Murmurs are blowing,
whooshing, or rasping sounds heard during a
heartbeat.
Tests used to diagnose pulmonary stenosis may
include:
Cardiac catheterization
Chest x-ray
ECG
Echocardiogram
MRI of the heart
53. Treatment
Sometimes, treatment may not be needed if the disorder is mild.
When there are also other heart defects, medications may be used
to:
Help blood flow through the heart (prostaglandins)
Help the heart beat stronger
Prevent clots (blood thinners)
Remove excess fluid (water pills)
Treat abnormal heartbeats and rhythms
Percutaneous balloon pulmonary dilation (valvuloplasty) may
be performed when no other heart defects are present.
This procedure is done through an artery in the groin.
The doctor sends a flexible tube (catheter) with a balloon attached
to the end up to the heart. Special x-rays are used to help guide
the catheter.
The balloon stretches the opening of the valve.
Some patients may need heart surgery to repair or replace the
pulmonary valve. The new valve can be made from different
materials. If the valve cannot be repaired or replaced, other
procedures may be needed.
54. Complications
Abnormal heartbeats (arrhythmias)
Death
Heart failure and enlargement of the right side of
the heart
Leaking of blood back into the right ventricle
(pulmonary regurgitation) after repair
55. NURSING CARE OF THE CHILD WITH CONGENITAL HEART
DISEASES.
Nursing Assessment: -
Obtain a through nursing history
Discuss the care plan with the health care team (cardiologist, cardiac
surgeon, nursing care manager, social worker, nutrition list)
Measure and record height and weight plot on a growth chart
Record vital signs and oxygen saturations.
Measure vital signs at a time when the infant / child is quit.
Choose appropriate size blood pressure cuff
Check four extremities BPxl.
Assess and record.
Skin color, pink, cyanotic, mottled
Mucous membranes; moist, dry, cyanotic
Extremities: check peripheral pulses for quality and symmetry,
dependent edema, capillary refill, color and temperature.
56. Assess for clubbing (cyanotic heart disease0
Assess chest wall for deformities; prominent pericardial
activity.
Assess respiratory pattern
Before disturbing the child, stand back on count the
respiratory rate.
Loosen or remove clothing to directly observe chest
movement
Assess for signs of respiratory distress; increased
respiratory rate, granting, retraction, nasal flaring.
Auscultate for crackles, wheezing, congestion, and
strider.
Assess heart sounds.
Determine rate (bradycardia, tachycardia) and rhythm(
regular or irregular)
Identity murmur (type, locations, and grade)
57. Assess fluids status.
Daily weights
Strict intake and output (number of wet diaper, urine
output)
Assess and record the child’s level of activity
Observe the infant while feeding, does the infant need
frequent breaks or child asleep during feeding,
assess for sweating, color change, or respiratory
distress while feeding.
Observe the child at play, is play interrupted to rest
Assess and record findings relevant to the child’s
development level, age appropriate behavior, cognitive
skill, gross and fine motor skills.
58. Summary: -
So far we have discussed about congenital heart diseases,
cyanotic heart disease like fallots tetrology, transposition of
great arteries and acynotic heart disease like VSD, ASD,
PDA and Nursing care of the child with congenital heart
disease.